Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes

NCT: NCT07276776 · COMPLETED

NCT IDNCT07276776
StatusCOMPLETED
Start Date2025-12-12
Completion2026-03-30

Brief Summary

This is a single arm feasibility study to evaluate the Omnipod M System in adults with Type 2 Diabetes with the aim to enroll to 40 participants aged 18-75 years with type 2 diabetes to have a minimum of 20 participants initiate the use of Omnipod M System and the goal of 16 participants completing the 6-week treatment period.

Frequently Asked Questions

What is An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes?

An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes is a clinical trial registered under NCT07276776. Current status: COMPLETED.

What is the status of NCT07276776?

The current status of NCT07276776 (An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes) is: COMPLETED.

When did An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes start?

An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes started on 2025-12-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑